Susan Hasty, Publisher
Table of Contents . . . April 8th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Breast Cancer Weekly | Other Publications
Hormone Replacement Therapy - Combined Estrogen/Progestin Therapy Significantly Increases Breast Cancer Risk
Adoptive Immunotherapy - Interleukin-2 and Natural Killer Cells Are Well Tolerated
Cancer Recurrence - Recurrence After Breast-Conserving Therapy Due to Residual Cancer Cells
Cancer Therapies - High-Dose Chemotherapy for Breast Cancer Contraindicated
Chemotherapy - Nitrogen Index Used to Predict Drug-Induced Toxicity
Hormone Receptors - Variable Estrogen and Progesterone Receptor Expression Could Have Implications for Breast Cancer Treatment
Prevention - Food-Derived Chemopreventive Agents Being Evaluated
Prognostics - Tumors with High PTA Levels Related to Poor Outcome
Risk Factors - Use of ACE Inhibitors, Calcium Channel Blockers Not Linked to Breast Cancer
Surgery - Sentinel Lymph Node Dissection Has High Success Rate
Diagnostics - p43-Positive Lymphocytes Help Diagnose Breast Cancer
Metastatic Cancer - Scientists Develop New Method for Detecting Breast Cancer Cells in Bone Marrow
Pharmacokinetics - Phase I Study Explores MDXH210/Interferon (gamma) Combination in Cancer Patients
Screening - Contrast Agent Enables Highly Detailed Breast Cancer Images Using Open MRI Scanners
Patent News - Additional Mammotest Stereotactic Breast Biopsy System Patent Received
Patent News - Claims Granted for Nontoxic Cancer Genomics Therapy
Patent News - Patent Filings Cover Markers and Targets in Breast Cancer and Neurological Disorders
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.